Clinical Trial Update: Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of telbivudine 600 mg tablets in Chinese patients with chronic hepatitis B completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Telbivudine (telbivudine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED